AeroCare Holdings, Inc. – Trademark Portfolio
Entity Type: 03
AeroCare Holdings, Inc. holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 7 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 3 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include ARX, BUYPAP, AEROCARE, BUYPAPUSA, and SLEEP A LITTLE EASIER. The owner is based in Oralando, FL.
3325 Bartlett Blvd.
Oralando, FL 32811
Showing of trademarks Trademarks
Trademark Classifications
AeroCare Holdings, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does AeroCare Holdings, Inc. have?
AeroCare Holdings, Inc. has 9 U.S. trademarks filed with the USPTO. Of these, 6 registered, 1 abandoned, 2 cancelled.
What trademark classes does AeroCare Holdings, Inc. file in?
AeroCare Holdings, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 44 (Medical Services), Class 10 (Medical Apparatus). Class 35 covers advertising; business management; business administration; office functions.
What are AeroCare Holdings, Inc.'s most well-known trademarks?
AeroCare Holdings, Inc.'s registered trademark portfolio includes well-known marks such as ARX, BUYPAP, AEROCARE, BUYPAPUSA, and SLEEP A LITTLE EASIER. These are among 6 currently registered trademarks in the portfolio.
What is AeroCare Holdings, Inc.'s trademark registration success rate?
AeroCare Holdings, Inc. has a 67% trademark registration rate, with 6 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.